ERBB2 and cancer: To investigate the effect of EGFR pathway inhibition on EGFR clustering, we imaged the transfected SW620 cells in the presence of EGFR pathway inhibitors cetuximab or trastuzumab, two commonly used anti-cancer drugs, which separately target EGFR and HER2, respectively.